Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The small EDRK-rich factor 2 pseudogene (ENSG00000270257) shares sequence homology with the functional *SERF2* gene, which encodes a small protein with high content of the amino acids glutamic acid (E), aspartic acid (D), arginine (R), and lysine (K)[5]. Pseudogenes are nonfunctional DNA segments that resemble known genes, but lack the ability to produce functional protein products due to disabling mutations such as frameshifts, premature stop codons, or loss of regulatory elements[2][4][6]. While some pseudogenes have been implicated in subtle regulatory roles within cells, notably by acting as microRNA decoys, there is no established evidence supporting such a biological function for ENSG00000270257[6]. Consequently, it is not recognized as a therapeutic target, receptor, enzyme, transporter, or biomarker in clinical practice or drug development. If you need information about the functional version of this gene, refer to “Small EDRK-rich factor 2” (*SERF2*), not the pseudogene version[5].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small EDRK-rich factor 2 pseudogene (SERF2 pseudogene).